NCT04066309

Brief Summary

The aim of this study is to prospectively collect clinical data to confirm the safety and clinical performance of Neodent Titanium Base Abutment and Pro PEEK Abutment in daily dental practice setting, by means of a randomized clinical study of prosthetic rehabilitation using these devices. A total of 48 healed implant sites (at least 4 months post-extraction) shall be included during the sample enrollment (24 patients), which will be randomly divided into two groups, so that each patient receives one implant from each group (removal and non-removal of the abutment placed at the time of surgery). Patients will be followed for 24 months after implant loading. It is expected that there is no difference in peri-implant bone level change between the two treatment groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 26, 2019

Completed
7 days until next milestone

Study Start

First participant enrolled

September 2, 2019

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

November 13, 2023

Status Verified

November 1, 2023

Enrollment Period

4.2 years

First QC Date

August 19, 2019

Last Update Submit

November 8, 2023

Conditions

Keywords

Dental ImplantsBone-Implant InterfaceMouth Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Amount of peri-implant bone level change

    Peri-implant bone level will be measured on the periapical radiographs obtained as the distance between the coronal margin of the implant shoulder and the most coronal point of the peri-implant bone, on the mesial and distal surfaces of each implant. The horizontal measurement of the remodeling will be done, when there is no bone contact in the cervical part of the implant. This measurement will be performed from the superior site of the bone crest to the lateral edge of the implant, perpendicular to the long axis of the implant.

    2, 6, 12 and 24 months after implant loading

Secondary Outcomes (3)

  • Implant survival

    2, 6, 12 and 24 months after implant loading

  • Implant success

    2, 6, 12 and 24 months after implant loading

  • Prosthetic survival

    2, 6, 12 and 24 months after implant loading

Other Outcomes (5)

  • Prosthetic success

    2, 6, 12 and 24 months after implant loading

  • Patient Satisfaction: OHIP-14 (Oral Health Impact Profile) questionnaire

    Baseline, 2, 6, 12 and 24 months after implant loading

  • Clinician Satisfaction: VAS (Visual Analogue Scale) questionnaire

    Baseline, 21 days, 2, 6, 12 and 24 months after implant loading

  • +2 more other outcomes

Study Arms (2)

Abutment removal

EXPERIMENTAL

At the time of surgery, customizable healing abutments will be placed on implants. These will be replaced by Pro PEEK Abutments 21 days later to placement of temporary prostheses (loading). The final abutments (Titanium Bases) and final prostheses will be inserted 2 months after loading.

Device: Neodent GM Helix ImplantDevice: GM Customizable Healing AbutmentDevice: GM Pro PEEK AbutmentDevice: GM Exact Titanium Base

Final abutment

EXPERIMENTAL

The final abutments (Titanium Bases) will be placed at the time of the implant placement surgery and will stay at mouth during all period of the study. Temporary and final prosthesis will be placed on Titanium Bases.

Device: Neodent GM Helix ImplantDevice: GM Exact Titanium Base

Interventions

4.0x10 mm Neodent GM Helix Implants will be placed 2mm subcrestally (in relation to the buccal bone plate) in the posterior region of the maxilla, under local anesthesia and with adequate bone bed preparation, as recommended by the manufacturer, using the guided surgery technique.

Abutment removalFinal abutment

Customizable healing abutments will be placed at the time of implant placement.

Abutment removal

Placement of temporary single prostheses (early loading), over temporary abutments.

Abutment removal

Insertion of the final abutment (Titanium Base and Zirconia Coping), following the digital workflow.

Abutment removalFinal abutment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older;
  • upper posterior teeth missing, with adjacent natural tooth;
  • Healed implant sites (at least 4 months post-extraction);
  • Qualify for placement of 4.0x10 mm Neodent GM Helix implants;
  • Adequate bone height to allow the 2mm subcrestal placement of a 10-mm-long implant.

You may not qualify if:

  • Signs of allergy or hypersensitivity to the chemical ingredients of the materials: titanium, titanium alloy (Ti6Al4V-ELI) or PEEK (Polyetheretherketone);
  • Presence of acute inflammatory or infectious processes in live tissue;
  • Unsuitable bone volume or quality;
  • Serious medical problems (e.g. bone metabolism disorders, blood clotting disorders, unsuitable healing capacity);
  • Insufficient oral hygiene;
  • Incomplete jawbone growth;
  • Patient uncooperative and not motivated;
  • Abuse of drugs or alcohol;
  • Psychosis;
  • Prolonged functional disorders which resist any treatment with medications;
  • Xerostomia;
  • Weakened immunological system;
  • Diseases which require the use of steroids;
  • Uncontrolled endocrinological diseases;
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Latino Americano de Pesquisa e Ensino Odontológico (ILAPEO)

Curitiba, Paraná, 80710-150, Brazil

Location

MeSH Terms

Conditions

Jaw, Edentulous, Partially

Condition Hierarchy (Ancestors)

Jaw, EdentulousJaw DiseasesMusculoskeletal DiseasesStomatognathic DiseasesMouth, EdentulousMouth DiseasesTooth Diseases

Study Officials

  • Larissa Trojan, PhD

    Neodent

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two implants (one of each group) will be placed on each subject at the same stage.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2019

First Posted

August 26, 2019

Study Start

September 2, 2019

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

November 13, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations